Resistance is also developed against antihormonal treatment and aromatase inhibitors, highlighting the importance of hormones in tumour homeostasis (Ring and Dowsett, 2004; Dowsett et al, 2005; Weinberg et al, 2005). Here, CYP19A1 is linked to neoplasm.